Literature DB >> 15032319

Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.

Swayam Prabha1, Vinod Labhasetwar.   

Abstract

PURPOSE: The aim of the study was to determine the critical determinants in nanoparticle-mediated gene transfection. It was hypothesized that different formulation parameters could affect the nanoparticle characteristics and hence its gene transfection.
METHODS: Nanoparticles encapsulating plasmid DNA encoding for firefly luciferase were formulated using polylactide (PLA) and poly (D,L-lactide-co-glycolide) (PLGA) polymers of different compositions and molecular weights. A multiple-emulsion solvent-evaporation method with polyvinyl alcohol (PVA) as an emulsifier was used to formulate DNA-loaded nanoparticles. Gene expression of nanoparticles was determined in breast cancer (MCF-7) and prostate cancer (PC-3) cell lines.
RESULTS: Nanoparticles formulated using PLGA polymer demonstrated greater gene transfection than those formulated using PLA polymer, and this was attributed to the higher DNA release from PLGA nanoparticles. Higher-molecular-weight PLGA resulted in the formation of nanoparticles with higher DNA loading, which demonstrated higher gene expression than those formulated with lower-molecular-weight PLGA. In addition, the nanoparticles with lower amount of surface-associated PVA demonstrated higher gene transfection in both the cell lines. Higher gene transfection with these nanoparticles was attributed to their higher intracellular uptake and cytoplasmic levels. Further study demonstrated that the molecular weight and the degree of hydrolyzation of PVA used as an emulsifier also affect the gene expression of nanoparticles.
CONCLUSIONS: Results thus demonstrate that the DNA loading in nanoparticles and its release, and the surface-associated PVA influencing the intracellular uptake and endolysosomal escape of nanoparticles, are some of the critical determinants in nanoparticle-mediated gene transfection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032319     DOI: 10.1023/b:pham.0000016250.56402.99

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

1.  Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles.

Authors:  H Cohen; R J Levy; J Gao; I Fishbein; V Kousaev; S Sosnowski; S Slomkowski; G Golomb
Journal:  Gene Ther       Date:  2000-11       Impact factor: 5.250

Review 2.  Endosomes, lysosomes: their implication in gene transfer.

Authors:  R Wattiaux; N Laurent; S Wattiaux-De Coninck; M Jadot
Journal:  Adv Drug Deliv Rev       Date:  2000-03-30       Impact factor: 15.470

Review 3.  Nonviral gene therapy: promises and challenges.

Authors:  S Li; L Huang
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

4.  Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles.

Authors:  Swayam Prabha; Wen-Zhong Zhou; Jayanth Panyam; Vinod Labhasetwar
Journal:  Int J Pharm       Date:  2002-09-05       Impact factor: 5.875

5.  Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses.

Authors:  M L Hedley; J Curley; R Urban
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

6.  Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

Authors:  R Jeyanthi; R C Mehta; B C Thanoo; P P DeLuca
Journal:  J Microencapsul       Date:  1997 Mar-Apr       Impact factor: 3.142

7.  Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells.

Authors:  Mini Thomas; Alexander M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-25       Impact factor: 11.205

8.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method.

Authors:  H Murakami; M Kobayashi; H Takeuchi; Y Kawashima
Journal:  Int J Pharm       Date:  1999-10-05       Impact factor: 5.875

9.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Authors:  Vladimir P Torchilin; Tatyana S Levchenko; Ram Rammohan; Natalia Volodina; Brigitte Papahadjopoulos-Sternberg; Gerard G M D'Souza
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 10.  Systemic gene therapy with p53 inhibits breast cancer: recent advances and therapeutic implications.

Authors:  Q R Chen; A J Mixson
Journal:  Front Biosci       Date:  1998-09-15
View more
  31 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 2.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

Review 3.  Encapsulation of nucleic acids and opportunities for cancer treatment.

Authors:  Lisa Brannon-Peppas; Bilal Ghosn; Krishnendu Roy; Kenneth Cornetta
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

4.  Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents.

Authors:  Sasivimon Pramual; Apinya Assavanig; Magnus Bergkvist; Carl A Batt; Panya Sunintaboon; Kriengsak Lirdprapamongkol; Jisnuson Svasti; Nuttawee Niamsiri
Journal:  J Mater Sci Mater Med       Date:  2015-12-28       Impact factor: 3.896

5.  Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsions.

Authors:  Aaron S Mayo; Balamurali K Ambati; Uday B Kompella
Journal:  Int J Pharm       Date:  2009-12-16       Impact factor: 5.875

6.  Selective biophysical interactions of surface modified nanoparticles with cancer cell lipids improve tumor targeting and gene therapy.

Authors:  Blanka Sharma; Chiranjeevi Peetla; Isaac M Adjei; Vinod Labhasetwar
Journal:  Cancer Lett       Date:  2013-03-21       Impact factor: 8.679

7.  Preparation and Characterization of Cationic PLA-PEG Nanoparticles for Delivery of Plasmid DNA.

Authors:  Weiwei Zou; Chunxi Liu; Zhijin Chen; Na Zhang
Journal:  Nanoscale Res Lett       Date:  2009-05-21       Impact factor: 4.703

8.  Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2008-08-08       Impact factor: 12.479

Review 9.  Nanotechnology in urology.

Authors:  Shihua Jin; Vinod Labhasetwar
Journal:  Urol Clin North Am       Date:  2009-05       Impact factor: 2.241

10.  Poly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin delivery.

Authors:  Jie Liu; Zhaozhong Jiang; Shengmin Zhang; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-07-25       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.